Immunovant, Inc. IMVT Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s net income?
- Immunovant, Inc. (IMVT) reported net income of -$147.86M in Q1 2026.
- How has Immunovant, Inc.'s net income changed year-over-year?
- Immunovant, Inc.'s net income decreased by 38.9% year-over-year, from -$106.45M to -$147.86M.
- What is the long-term trend for Immunovant, Inc.'s net income?
- Over 4 years (2022 to 2026), Immunovant, Inc.'s net income has grown at a 34.0% compound annual growth rate (CAGR), from -$156.73M to -$505.61M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.